Relevium Technologies Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RLLVF research report →
Price Chart
About the company
Relevium Technologies Inc. operates within the health and wellness sector, focusing on identifying, assessing, acquiring, and managing various brands and businesses, primarily through e-commerce channels. The company distributes a range of products, including dietary supplements, nutraceuticals, sports nutrition items, and cosmeceuticals, mainly through its Bioganix online brand.
- CEO
- Aurelio Useche
- IPO
- 2017
- HQ
- Montreal, QC, CA
Get TickerSpark's AI analysis on RLLVF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.98M
- P/E
- -0.32
- PEG
- 0.00
- P/S
- 2.98
- P/B
- -0.35
- EV/EBITDA
- -1.27
- Div Yield
- 0.00%
- Gross Margin
- 45.37%
- Op Margin
- -161.49%
- Net Margin
- -587.57%
- ROE
- 221.45%
- ROIC
- 88.93%
Latest fiscal year · YoY change
- Revenue
- $913.64K-69.3%
- Gross Profit
- $414.48K-65.3%
- Op Income
- $-1,475,457
- Net Income
- $-5,368,336+22.6%
- EPS
- $-0.03+30.2%
- OCF Growth
- +94.1%
- FCF Growth
- +94.1%
- 52W High
- $0.22
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 2.51
- RSI (14)
- 52
- Avg Volume
- 56
No earnings-call transcripts are available for RLLVF yet.
- Free Float
- 96.8%
- Shares Outstanding
- 329.49M
- Float Shares
- 318.88M
Our RLLVF coverage
Recent articles, reports, and earnings notes.
No research on RLLVF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RLLVF report →Relevium Technologies Completes Shares-For-Debt Transactions
globenewswire.com · Oct 1
Relevium Obtains Conditional TSXV Approval for the Settlement of the Outstanding Notes in Shares
globenewswire.com · Aug 10
Relevium Announces Settlement of the Outstanding Notes
globenewswire.com · Jun 30
Relevium Announces Shareholder Townhall and Conference Call
globenewswire.com · Jun 15
Relevium Announces Maturity of the Outstanding Convertible Debenture Notes and Begins Negotiations With Debenture Holders
globenewswire.com · Jun 10
Relevium Announces the Appointment of Dr. Wolfgang Renz as Chief Scientific Officer for Biocannabix Health Corporation
globenewswire.com · May 20
Relevium Provides Update on the Exclusive Supply of Medical Examination Gloves
globenewswire.com · May 5
Biocannabix Enters Into LOI With IAM Health GmbH
globenewswire.com · Apr 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.